AKERBLOM, J.S, CANNON, C, EMANUELSSON, G, ET AL (WILCOX, R.G and MEMBER OF THE DSMB), 2009. Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndrome: Rationale, design and baseline characteristics of the PLATelet inhibition and patient Outcome trial.: PLATO American Heart Journal. 157, 599-605
CARVER, A, RAFELT, S, GERSHLICK, A.H, FAIRBROTHER, K.L, HUGHES, S and WILCOX, R.G. FOR THE REACT INVESTIGATORS., 2009. Longer-Term Follow-Up of Patients Recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) Trial Journal of the American College of Cardiology. 54(2),
MEGA, J.L, BRAUNWALD, E, MOHANAVELU, S and ET AL (WILCOX, R.G. STEERING COMMITTEE AND UK LEAD INVESTIGATOR), 2009. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. The Lancet. 374, 29-38
WALLENTIN, L., BECKER, R.C., BUDAJ, A., CANNON, C.P., ET AL (WILCOX, R.G and MEMBER OF THE DSMB), 2009. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome: PLATO The New England Journal of Medicine. 361(11), 1045-1057
TANGELDER, M, FRISON, L, WEAVER, D, WILCOX, R, BYLOCK, A, EMANUELSSON, H, HELD, P and AND OLDGREN, J., 2008. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial American Heart Journal. 155(2), 382-387 WILCOX, R.G, KUPFER, S, AND ERDMANN, E and ON BEHALF OF THE PROACTIVE STUDY INVESTIGATORS., 2008. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: Results from PROspective pioglitAzone Clinical Trial in macro Vascular Events (PROactive 10) American Heart Journal. 155(1), (In Press.)
ALP, N.J, GERSHLICK, A.H, CARVER, A, STEVENS, S.E and WILCOX, R.G., 2008. Rescue angioplasty for failed thrombolysis in older patients: Insights from the REACT trial. International Journal of Cardiology. 125(2), 254-257
ERDMANN, E and AND WILCOX, R.G., 2008. Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure European Heart Journal. 29(1), 12-20
WILCOX, R., BOUSSER, M-G., PIRAG, V., BETTERIDGE, J., SCHERNTHANER, G., KUPFER, S. and DORMANDY, J., 2007. Effects of pioglitazone in patients with Type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04). Stroke. 38(3), 865-873 XAVIER, R, WHITE, A, FOX, S, WILCOX, R and AND HEPTINSTALL, S., 2007. Enhanced platelet aggregation and activation under conditions of hypothermia Thrombosis and Haemostasis. 98(6), 1266-1275
STOREY, R., HARRINGTON, R, A., HUSTED, S., HEPTINSTALL, S., WILCOX, R., GURBEL, A., GRANDE, P., WICKENS, M., PETERS, G., EMANUELSSON, H. and CANNON, C., 2007. AZD6140 Suppresses Platelet Aggregation in Clopidogrel-Treated Patients Even in Those With High Aggregation Levels JACC. 49(9 (Supplement A)),
STOREY, R.F, HUSTED, S, HARRINGTON, R.A, HEPTINSTALL, S, WILCOX, R.G, PETERS, G, WICKENS, M, EMANUELSSON, H, GURBEL, P, GRANDE, P and AND CANNON, C.P., 2007. Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12 Receptor Antagonist, Compared with Clopidogrel in Patients with Acute Coronary Syndromes. Journal of the American College of Cardiology. 50(19), 1852-1856 (In Press.)
ERDMANN, E., WILCOX, R., PEREZ, A., YATES, J., SPANHEIMER, R. and DORMANDY, J., 2007. Mortality after Serious Heart Failure: Results from PROactive JACC. 49(9), 66A
ERDMANN, E, DORMANDY, J, WILCOX, R, MASSI-BENEDETTI, M and AND CHARBONNEL, B., 2007. PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactuve study Vascular Health and Risk Management. 3(4), 355-370
WIVIOTT, S.D, BRAUNWALD, E, MCCABE, C.H and ET AL. (WILCOX, R.G. UK PRINCIPAL INVESTIGATOR AND STEERING COMMITTEE MEMBER)., 2007. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes The New England Journal of Medicine. 357(20), 2001-15 (In Press.)
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54 RAO, ARCHANA, ASADI-LARI, MOHSEN, WALSH, JOHN, WILCOX, ROBERT and GRAY, DAVID, 2006. Quality of life in patients with signs and symptoms of heart failure - does systolic function matter? Journal of cardiac failure. 12(9), 677-83 HOUGHTON A. and GRAY D., 2006. In: HODDER, ed., Making Sense of the ECG. A hands-on guide.: International Student's Edition 2nd ed. Edward Arnold. 278
STOREY R.F., HUSTED S, HARRINGTON R.A., HEPTINSTALL S., WILCOX R.G. and ET AL., 2006. AZD6140 Yields greater inhibition of platelet aggregation than clopidogrel in patients with acute coronary syndromes without previous clopidogrel treatment. In: 204 (A821)
WILCOX, R.G., BOUSSER, M-G. and DORMANDY, J. ON BEHALF OF THE PROACTIVE INVESTIGATORS., 2006. The effects of pioglitazone in patients with or without a history of stroke (> 6 months prior to randomisation) - a pre-specified subgroup analysis of PROactive. In: World Congress of Cardiology. A204 (no 821-4).
STOREY R.F., HARRINGTON R.A., HUSTED S., HEPTINSTALLS., WILCOX R.G. and ET AL, 2006. AZD6140 Yields additional suppression of platelet aggregation in patients with acute coronary syndrome previously treated with clopidogrel. In: 204 (A821-4)
WILCOX, R., 2006. An Analysis from PROactive on the effects of pioglitazone on major adverse cardiovascular events (MACE) and myocardial infarction. Diabetologia. 49 (Supplement 1)(72),
WILCOX, R., 2006. An analysis from PROactive on the Effects of Pioglitazone on Myocardial Infarction and Major Adverse Cardiovascular Events (MACE) in Patients with Type 2 Diabetes (Abstract). European Heart Journal. 27(supplement)(535),
BODY, S., ASGARI, K., RICKARD, J. F., ZHANG, Z., FONE, K. C., BRADSHAW, C. M. and SZABADI, E., 2005. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour Psychopharmacology. VOL 181(NUMBER 2), 289-298 GERSHLICK, A.H., STEPHENS-LLOYD, A., HUGHES, S., ABRAMS, K.R., STEVENS, S.E., UREN, N.G., DE BELDER, A., DAVIS, J., PITT, M., BANNING, A., BAUMBACH, A., SHIU, M.F., SCHOFIELD, P., DAWKINS, K.D., HENDERSON, R.A., OLDROYD, K. and WILCOX, R.G., 2005. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction New England Journal of Medicine. 353(26), 2758-2768 DORMANDY, J.A., CHARBONNEL, B., ECKLAND, D.J.A., ERDMANN, E., MASSI-BENEDETTI, M., MOULES, I.K., SKENE, A.M., TAN, M.H., LEFÈBVRE, P.J., MURRAY, G.D., STANDL, E., WILCOX, R.G., WILHELMSEN, L., BETTERIDGE, J., BIRKELAND, K., GOLAY, A., HEINE, R.J., KORÁNYI, L., LAAKSO, M., MOKÁŇ, M., NORKUS, A., PIRAGS, V., PODAR, T., SCHEEN, A., SCHERBAUM, W., SCHERNTHANER, G., SCHMITZ, O., ŠKRHA, J., SMITH, U., TATOŇ, J. and ON BEHALF OF THE PROACTIVE INVESTIGATORS, 2005. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 366(9493), 1279-1289 SABATINE, M.S., CANNON C.P., GIBSON, C.M., LÓPEZ-SENDÓN, J.L., MONTALESCOT, G., THEROUX, P., CLAEYS, M.J., COOLS, F., HILL, K.A., SKENE, A.M., MCCABE, C.H. and BRAUNWALD, E., 2005. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation New England Journal of Medicine. 352(12), 1179-1189 WILCOX,R.G., 2005. General principles of fibrinolytic therapy in acute myocardial infarction.. In: Coronary Reperfusion Therapy in Clinical Practice. Taylor & Francis Ltd, London. 43-64
GERSHLICK, A.H., HUGHES, S.L., STEPHENS-LLOYD, A. and WILCOX, R.G., 2005. Rescue angioplasty v conservative treatment or repeat thrombolysis for failed lysis: 6 months outcome according to treatment actually received In: European Society of Cardiology, Stockholm September 2005. P3426, p562
BRENER, S. J., LINCOFF, A. M., BATES, E. R., JIA, G., ARMSTRONG, P. W., GUETTA, V., HOCHMAN, J. S., SAVONITTO, S., WILCOX, R. G. and WHITE, H. D., 2005. The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial American Heart Journal. VOL 150(NUMBER 1), 89-93 GERSHLICK, A.H., HUGHES, S. and WILCOX, R.G., 2005. The REACT (Rescue Angioplasty v. Conservative Treatment or Repeat Thrombolysis) Trial: Impact of age upon efficacy of treatment. In: British Cardiac Society proceedings. A24
TOFF, W.D., CAMM, A.J., SKEHAN, D. and (WILCOX, R.G. INVESTIGATOR), 2005. Single-chamber versus dual pacing for high-grade atrioventricular block. New England Journal of Medicine. 353(2), 145-155 GERSHLICK, A.H., UREN, N., DE BELDER, A. and WILCOX, R.G., 2005. The REACT (Rescue Angioplasty v. Conservative Treatment or Repeat Thrombolysis) Trial: Results according to actual treatment received. In: British Cardiac Society, Annual Scientific Conference, 23-26 May 2005. A22, No A063
GURM, H. S., SAREMBOCK, I. J., KEREIAKES, J., YOUNG, J. J., HARRINGTON, R. A., KLEIMAN, N., FEIT, F., WOLSKI, K., BITTL, J. A. and WILCOX, R., 2005. Use of Bivalirudin During Percutaneous Coronary Intervention In Patients With Diabetes Mellitus: An Analysis From the Randomized Evaluation in Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 Trial American College of Cardiology. Journal. VOL 45(NUMB 12), 1932-1938 NALLAMOTHU, BRAHMAJEE K, BATES, ERIC R, HOCHMAN, JUDITH S, GRANGER, CHRISTOPHER B, GUETTA, VICTOR, WILCOX, ROBERT G, WHITE, HARVEY D, ARMSTRONG, PAUL W, SAVONITTO, STEFANO, JIA, GANG and LINCOFF, A MICHA, 2005. Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial. European Heart Journal. 26(15), 1506-12 WILCOX, R.G., AMBROSIONI R., PATNI R., MUKERHERJEE R. and PITT B., 2005. Effect of eplerenone in patients with normal renal function and mild renal insufficiency: results from the EPHESUS trial. In: European Society of Cardiology.. PO P1772
GERSHLICK, A.H., STEPHENS-LLOYD, A. and WILCOX, R.G., 2005. Rescue angioplasty v conservative treatment or repeat thrombolysis for failed thrombolysis in acute MI: the REACT trial one year clinical outcome. In: European Society of Cardiology, Stockholm, Sept 2005. 562
FOX, K. A. A., BIRKHEAD, J., WILCOX, R., KNIGHT, C. and BARTH, J., 2004. British Cardiac Society Working Group on the definition of myocardial infarction Heart. VOL 90(PART 6), 603-609 SAW, J., LINCOFF, A. M., DESMET, W., BETRIU, A., RUTSCH, W., WILCOX, R. G., KLEIMAN, N. S., WOLSKI, K., TOPOL, E. J. and REPLACE-2 INVESTIGATORS, 2004. Lack of Clopidogrel Pretreatment Effect on the Relative Efficacy of Bivalirudin With Provisional Glycoprotein IIb/IIIa Blockade Compared to Heparin With Routine Glycoprotein IIb/IIIa Blockade: A REPLACE-2 Substudy American College of Cardiology. Journal. VOL 44(NUMB 6), 1194-1199 CHARBONNEL, B., DORMANDY, J., ERDMANN, E., MASSI-BENEDETTI, M., SKENE, A.M. and WILCOX, R.G., 2004. The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive). Diabetes Care. 27(7), 1647-1653 LINCOFF, A MICHAEL, KLEIMAN, NEAL S, KEREIAKES, DEAN J, FEIT, FREDERICK, BITTL, JOHN A, JACKMAN, J DANIEL, SAREMBOCK, IAN J, COHEN, DAVID J, SPRIGGS, DOUGLAS, EBRAHIMI, RAMIN, KEREN, GADI, CARR, JEFFREY, COHEN, ERIC A, BETRIU, AMADEO, DESMET, WALTER, RUTSCH, WOLFGANG, WILCOX, ROBERT G, DE FEYTER, PIM J, VAHANIAN, ALEC, TOPOL, ERIC J and ,, 2004. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. Journal of the American Medical Association. 292(6), 696-703 GURM, HITINDER S, LINCOFF, A MICHAEL, LEE, DAVID, TANG, W H WILSON, JIA, GANG, BOOTH, JOAN E, CALIFF, ROBERT M, OHMAN, E M, VAN DE WERF, FRANS, ARMSTRONG, PAUL W, GUETTA, VICTOR, WILCOX, ROBERT, TOPOL, ERIC J and ,, 2004. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial. American College of Cardiology. Journal. 43(4), 542-8 WILCOX, R.G., 2004. Combination of the oral direct thrombin inhibitor Ximelagatran with acetyl salicylic acid (ASA) after acute myocardial infarction (MI): 1 year outcome following the start of 6 months treatment. Heart. 90(Suppl 2), 153
MENON, V., HARRINGTON, R. A., HOCHMAN, J. S., CANNON, C. P., GOODMAN, S. D., WILCOX, R. G., SCHUNEMANN, H. J. and OHMAN, E. M., 2004. Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest. VOL 126(NUMB 3), 549S-575S PATRONO, C. and WILCOX, R.G., 2004. European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. European Heart Journal. 25(2), 166-181
WALLENTIN, L., WILCOX, R.G., WEAVER, W.D., EMANUELSSON, H., GOODVIN, A., NYSTRÖM, P. and BYLOCK, A., 2003. Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial. Lancet. 362(9386), 789-797 PITT B., REMME W., ZANNAD F., ET AL and (WILCOX, R.G. STEERING COMMITTEE MEMBER AND UK PRINCIPAL INVESTIGATOR)., 2003. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine. 348(14), 1309-1321 HO, M.-Y., BODY, S., KHERAMIN, S., BRADSHAW, C. M. and SZABADI, E., 2003. Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio schedule Psychopharmacology. VOL 167(PART 2), 137-144 MCKENZIE, D.B. and WILCOX, R.G., 2003. Metformin and Chronic Heart Failure. Lancet. 362, 919.
MCKENZIE, DANIEL B and WILCOX, ROBERT G, 2003. Thrombolytics: prospects for new agents. Expert Opinion on Pharmacotherapy. 4(1), 41-54 MCKENZIE, DANIEL B and WILCOX, ROBERT G, 2003. Heart failure: treatment and ethnic origin. Lancet. 362(9387), 919
WALLENTIN, L.C., WILCOX, R.G., WEAVER, D., EMANUELSSON, H., GOODVIN, A., NYSTROM, P. and BYLOCK, A., 2003. Combination of the Oral Direct Thrombin Inhibitor Ximelagatran with Acetyl Salicylic Acid (ASA) after Acute myocardial infarction: 1-year Outcome. Clinical Science. IV-501Abs2284
CHO, LESLIE, BHATT, DEEPAK L, BRENNAN, DANIELLE, WILCOX, ROBERT G and TOPOL, ERIC J, 2003. Relation of insurance status to performance of coronary angiography in patients with unstable angina pectoris or acute myocardial infarction. American Journal of Cardiology. 91(6), 721-3 BRADSHAW,C.M., 2003. Neuropharmacology. In: HALLIGAN,P.W., KISCHKA, U. and MARSHALL, J.C, eds., Handbook of Clinical Neuropsychology Oxford University Press. 445-469
WONG, C. K., WHITE, H. D., WILCOX, R. G., CRIGER, D. A., CALIFF, R. M., TOPOL, E. J. and OHMAN, E. M., 2003. Significance of Atrial Fibrillation During Acute Myocardial Infarction, and its Current Management Insights from the GUSTO-3 Trial Cardiac Electrophysiology Review. VOL 7(NUMBER 3), 201-207 SAW, J., DESMET, W., LINCOFF, A.M., BETRIU, A., RUTCH, W., WILCOX, R.G., KLEIMAN, N.S. and TOPOL, E.J., 2003. Clopidogrel Pretreatment Does not Influence the Relative Efficacy of Bivalirudin with Provisional GPIIb/IIIa Blockade vs Heparin with Routine GPIIb/IIIa Blockade. A REPLACE-2 Substudy. Circulation (Baltimore). 108(17), Abs: 2597
ANDERSON, I. M., RICHELL, R. A. and BRADSHAW, C. M., 2003. The effect of acute tryptophan depletion on probabilistic choice Journal of Psychopharmacology. VOL 17(PART 1), 3-8 DESMET, W., SAW, J., LINCOFF, A. M., BETRIU, A., RUTSCH, W., WILCOX, R. G., KLEIMAN, N. S., TOPOL, E. J. and REPLACE-2, I., 2003. P2869 Does clopidogrel pretreatment influence the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade versus heparin with routine glycoprotein PIIb/IIIa blockade? A REPLACE-2 substudy European Heart Journal. VOL 24(NUMBER 5), 548 WILCOX, R.G., 2003. General Principles of Fibrinolytic Therapy in Acute MI. In: Fibrinolytic Therapy in Clinical Practice
KHERAMIN, S., BODY, S., MOBINI, S., HO, M.Y., VELAZQUEZ-MARTINEZ, D.N., BRADSHAW, C.M., SZABADI, E., DEAKIN, J.F. and ANDERSON, I.M., 2002. Effects of quinolinic acid-induced lesions of the orbital prefrontal cortex on inter-temporal choice: a quantitative analysis Psychopharmacology. 165(1), 9-17 BOERSMA, ERIC, HARRINGTON, ROBERT A, MOLITERNO, DAVID J, WHITE, HARVEY, THÉROUX, PIERRE, VAN DE WERF, FRANS, DE TORBAL, ANNEKE, ARMSTRONG, PAUL W, WALLENTIN, LARS C, WILCOX, ROBERT G, SIMES, JOHN, CALIFF, ROBERT M, TOPOL, ERIC J and SIMOONS, MAARTEN L, 2002. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 359(9302), 189-98 BODY, S., CHIANG, T. J., MOBINI, S., HO, M. Y., BRADSHAW, C. M. and SZABADI, E., 2002. Effect of 8-OH-DPAT on temporal discrimination following central 5-hydroxytryptamine depletion Pharmacology, Biochemistry and Behavior. VOL 71(NUMBER 4), 787-793 BODY, S., KHERAMIN, S., MOBINI, S., HO, M.-Y., VELAZQUEZ-MARTINEZ, D. N., BRADSHAW, C. M. and SZABADI, E., 2002. Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT-depleted rats Behavioural Pharmacology. VOL 13(PART 8), 603-614 MOBINI, S, BODY, S, HO, M-Y, BRADSHAW, C M, SZABADI, E, DEAKIN, J F W and ANDERSON, I M, 2002. Effects of lesions of the orbitofrontal cortex on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology. 160(3), 290-8 GRAHAM, S J, LANGLEY, R W, BALBOA, VERDUZCO A M, BRADSHAW, C M and SZABADI, E, 2002. Effects of ketanserin and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Journal of Psychopharmacology. 16(1), 15-22
SZABADI, E., LANGLEY, R.W. and BRADSHAW, C.M., 2002. Comparison of single doses of noradrenergic drugs on pupillary fatigue waves in a patient with excessive daytime sleepiness Journal of Sleep Research. 11(JSR 11 (Suppl. 1)), 260
HO, M-Y, VELáZQUEZ-MARTÃNEZ, D N, BRADSHAW, C M and SZABADI, E, 2002. 5-Hydroxytryptamine and interval timing behaviour. Pharmacology, Biochemistry and Behavior. 71(4), 773-85 LARGE, G.A., GRAY, D., WILCOX, R.G. and HAMPTON, J.R., 2002. Early revascularisation for non-ST-segment elevation acute coronary syndromes: an estimation of demand in the UK. European Heart Journal. 23((suppl S)), 585
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 2002. Relationship of the `fear-inhibited light reflex` to the level of state/trait anxiety in healthy subjects International Journal of Psychophysiology. VOL 43(NUMBER 2), 177-184 WONG, C.-K., WHITE, H. D., WILCOX, R. G., CRIGER, D. A., CALIFF, R. M., TOPOL, E. J., OHMAN, E. M. and GUSTO-III INVESTIGATORS, 2002. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-ill experience Heart. VOL 88(PART 4), 357-362 O`SHEA, J. C., WILCOX, R. G., SKENE, A. M., STEBBINS, A. L., GRANGER, C. B., ARMSTRONG, P. W., BODE, C., ARDISSINO, D., EMANUELSSON, H. and AYLWARD, P. E., 2002. Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone American Journal of Cardiology. VOL 90(NUMBER 12), 1374-1377 STOREY, R F, OLDROYD, K G and WILCOX, R G, 2001. Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thrombosis and Haemostasis. 85(3), 401-7
BODY, S., CHIANG, T.-J., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2001. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure Psychopharmacology. VOL 158(PART 3), 305-313 GRAHAM, S. J., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2001. Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man Journal of Psychopharmacology. VOL 15(PART 4), 243-250
PRETORIUS, J L, PHILLIPS, M, LANGLEY, R W, SZABADI, E and BRADSHAW, C M, 2001. Comparison of clozapine and haloperidol on some autonomic and psychomotor functions, and on serum prolactin concentration, in healthy subjects. British Journal of Clinical Pharmacology. 52(3), 322-6 ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2001. Effects of clonidine and diazepam on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. Journal of Psychopharmacology. 15(4), 237-42
ARONOW, H D, TOPOL, E J, ROE, M T, HOUGHTALING, P L, WOLSKI, K E, LINCOFF, A M, HARRINGTON, R A, CALIFF, R M, OHMAN, E M, KLEIMAN, N S, KELTAI, M, WILCOX, R G, VAHANIAN, A, ARMSTRONG, P W and LAUER, M S, 2001. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet. 357(9262), 1063-8 GIUGLIANO, R P, LLEVADOT, J, WILCOX, R G, GURFINKEL, E P, MCCABE, C H, CHARLESWORTH, A, THOMPSON, S L, ANTMAN, E M, BRAUNWALD, E and ,, 2001. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. European Heart Journal. 22(18), 1702-15 CANNON, C P, MCCABE, C H, WILCOX, R G, BENTLEY, J H and BRAUNWALD, E, 2001. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. American Journal of Cardiology. 87(5), 636-9, A10 LLEVADOT, D., GIUGLIANO, R., ANTMAN, E., WILCOX, R.G., GURFINKEL, E., HENRY, T., MCCABE, C.H., CHARLESWORTH, A., THOMPSON, S., NICOLAU, J., SADOWSKI, Z. and BRAUNWALD, E., 2001. Availability of on-site catheterisation and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. European Heart Journal. 22(22), 2104-2115 BROOKS, J. and WILCOX, R.G., 2001. Guidelines for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation.
GIUGLIANO, R. P., MCCABE, C. H., ANTMAN, E. M., CANNON, C. P., VAN DE WERF, F., WILCOX, R. G., BRAUNWALD, E. and THROMBOLYSIS IN MYOCARDIAL INFARCTION (TIMI) INVESTIGATORS BOSTON, 2001. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage American Heart Journal. VOL 141(PART 5), 742-750 GREENBAUM, A B, HARRINGTON, R A, HUDSON, M P, MACAULAY, C M, WILCOX, R G, SIMOONS, M L, BERDAN, L G, GUERCI, A, COKKINOS, D V, KITT, M M, LINCOFF, A M, TOPOL, E J, CALIFF, R M and OHMAN, E M, 2001. Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators. American College of Cardiology. Journal. 37(2), 492-8 PHILLIPS, M A, OXTOBY, E K, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2000. Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Journal of Psychopharmacology. 14(3), 258-65
BANJAR, W. M. A., GAZZAZ, J., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2000. Effects of high ambient temperature on parasympathetically mediated cardiovascular reflexes in normal man British Journal of Clinical Pharmacology. VOL 50(PART 4), 360-365 DAVIS, C., LANGLEY, R.W., HO, M., BRADSHAW, C.M. and SZABADI, E., 2000. Normative data on a computerized graded conditional discrimination (choice reaction time) task Clinical Neuropsychological Assessment. 3, 217-230
PHILLIPS, M. A., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 2000. The effects of some antidepressant durgs on prepulse inhibition of the acoustic startle (eyeblink) response and the NI/P2 auditory evoked response in man Journal of Psychopharmacology. VOL 14(PART 1), 40-45
TAVERNOR, S J, ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 2000. Effects of pentagastrin and the cold pressor test on the acoustic startle response and pupillary function in man. Journal of Psychopharmacology. 14(4), 387-94
PHILLIPS, M. A., SZABADI, E. and BRADSHAW, C. M., 2000. Comparison of the effects of clonidine and yohimbine on pupillary diameter at different illumination levels British Journal of Clinical Pharmacology. VOL 50(PART 1), 65-68 SZABADI, E. and BRADSHAW, C. M., 2000. Mechanisms of action of reboxetine Reviews in contemporary pharmacotherapy. VOL 11(PART 5), 267-282
CHIANG, T.-J., AL-RUWAITEA, A. S., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. The effect of d-amphetamine on performance on two operant timing schedules Psychopharmacology. VOL 150(PART 2), 170-184 DAVIS, C., HO, M., BRADSHAW, C.M. and SZABADI, E., 2000. Estimation of premorbid performance on Raven's Standard Progressive Matrices using reading-test performance: New normative data Clinical Neuropsychological Assessment. 2, 113-123
MOBINI, S., CHIANG, T.-J., AL-RUWAITEA, A. S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis Psychopharmacology. VOL 149(PART 3), 313-318 CHIANG, T.-J., AL-RUWAITEA, A. S. A., MOBINI, S., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on performance on two operant timing schedules Psychopharmacology. VOL 151(PART 4), 379-391 MOBINI, S., CHIANG, T.-J., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat Psychopharmacology. VOL 152(PART 1), 47-54 MOBINI, S., CHIANG, T.-J., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 2000. Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement Psychopharmacology. VOL 152(PART 4), 390-397 WONG, C K, WHITE, H D, WILCOX, R G, CRIGER, D A, CALIFF, R M, TOPOL, E J and OHMAN, E M, 2000. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. American Heart Journal. 140(6), 878-85 BOERSMA, E., PIEPER, K. S., STEYERBERG, E. W., WILCOX, R. G., CHANG, W.-C., LEE, K. L., AKKERHUIS, K. M., HARRINGTON, R. A., DECKERS, J. W. and ARMSTRONG, P. W., 2000. Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation: Results From an International Trial of 9461 Patients Circulation (Baltimore). VOL 101(PART 22), 2557-2567
AKKERHUIS, K M, NEUHAUS, K L, WILCOX, R G, VAHANIAN, A, BOLAND, J L, HOFFMANN, J, BAARDMAN, T, NEHMIZ, G, ROTH, U, KLOOTWIJK, A P, DECKERS, J W, SIMOONS, M L and ,, 2000. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study. European Heart Journal. 21(24), 2042-55 KLEIMAN, N S, LINCOFF, A M, FLAKER, G C, PIEPER, K S, WILCOX, R G, BERDAN, L G, LORENZ, T J, COKKINOS, D V, SIMOONS, M L, BOERSMA, E, TOPOL, E J, CALIFF, R M and HARRINGTON, R A, 2000. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators. Circulation (New York, N.Y.). 101(7), 751-7
HASDAI, D, HOLMES, D R, CRIGER, D A, TOPOL, E J, CALIFF, R M, WILCOX, R G, PAOLASSO, E, SIMOONS, M, DECKERS, J and HARRINGTON, R A, 2000. Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators. American Heart Journal. 139(3), 454-60 TOPOL, E. J., OHMAN, E. M., ARMSTRONG, P. W., WILCOX, R., SKENE, A. M., AYLWARD, P., SIMES, J., DALBY, A., BETRIU, A. and BODE, C., 2000. Survival Outcomes 1 Year After Reperfusion Therapy With Either Alteplase or Reteplase for Acute Myocardial Infarction: Results From the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial Circulation (Baltimore). VOL 102(PART 15), 1761-1765
WONG, C.K., WHITE, H.D., WILCOX, R.G., CRIGER, D.A., CALIFF, R.M., TOPOL, E.J. and OHMAN, E.M., 2000. Does antiarrhythmic treatment alter outcome in AF complicating acute MI? The GUSTO III experience. Circulation (Baltimore). 102(18), 2779 Suppl.S
BERTRAND, M.E., RUPPRECHT, H.J., GERSHLICK, A.H. and WILCOX, R.G., 2000. Double-blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination with Aspirin Compared with Ticlopidine in Combination with Aspirin After Coronary Stenting. The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) Circulation (Baltimore). 102, 624-629
CANNON, C P, MCCABE, C H, WILCOX, R G, LANGER, A, CASPI, A, BERINK, P, LOPEZ-SENDON, J, TOMAN, J, CHARLESWORTH, A, ANDERS, R J, ALEXANDER, J C, SKENE, A and BRAUNWALD, E, 2000. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation (New York, N.Y.). 102(2), 149-56
AKKERHUIS, K M, DECKERS, J W, BOERSMA, E, HARRINGTON, R A, STEPINSKA, J, MAHAFFEY, K W, WILCOX, R G, LINCOFF, A M, KELTAI, M, TOPOL, E J, CALIFF, R M and SIMOONS, M L, 2000. Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. European Heart Journal. 21(5), 371-81 BROWN, N, MELVILLE, M, GRAY, D, YOUNG, T, SKENE, A M, WILCOX, R G and HAMPTON, J R, 1999. Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis. Heart. 81(6), 598-602 AL-RUWAITEA, A S, CHIANG, T J, HO, M Y, BRADSHAW, C M and SZABADI, E, 1999. Effect of central 5-hydroxytryptamine depletion on changeover behaviour in concurrent schedules of reinforcement. Psychopharmacology. 144(3), 264-71 PHILLIPS, M A, SZABADI, E and BRADSHAW, C M, 1999. The effects of the novel anxiolytic drug lesopitron, a full and selective 5-HT1A receptor agonist, on pupil diameter and oral temperature in man: comparison with buspirone. Journal of Psychopharmacology. 13(4), 391-7
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1999. Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man. Journal of Psychopharmacology. 13(1), 3-9
HO, M.-Y., MOBINI, S., CHIANG, T.-J., BRADSHAW, C. M. and SZABADI, E., 1999. Theory and method in the quantitative analysis of "impulsive choice" behaviour: implications for psychopharmacology Psychopharmacology. VOL 146(NUMBER 4), 362-372 ABDEBNAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1999. Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein British Journal of Clinical Pharmacology. VOL 48(NUMBER 3), 345-354 CHIANG, T J, AL-RUWAITEA, A S, HO, M Y, BRADSHAW, C M and SZABADI, E, 1999. Effect of central 5-hydroxytryptamine depletion on performance in the free-operant psychophysical procedure: facilitation of switching, but no effect on temporal differentiation of responding. Psychopharmacology. 143(2), 166-73 AL-RUWAITEA, A. S. A., CHIANG, T.-J., AL-ZAHRANI, S. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1999. Effect of central 5-hydroxytryptamine depletion on tolerance of delay of reinforcement: evidence from performance in a discrete-trials "time-left" procedure Psychopharmacology. VOL 141(NUMBER 1), 22-29 DAVIS, C, BRADSHAW, C M and SZABADI, E, 1999. The Doors and People Memory Test: validation of norms and some new correction formulae. British Journal of Clinical Psychology. 38 ( Pt 3), 305-14 BITSIOS, P., PHILPOTT, A., LANGLEY, R. W., BRADSHAW, C. M. and SZABADI, E., 1999. Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man Journal of Psychopharmacology. VOL 13(NUMBER 3), 226-234 WILCOX, R.G., 1999. Trial of early nifedipine in acute myocardial infarction: the TRENT Study. In: Efficacy of Myocardial Infarction Therapy: an evaluation of Clinical Trials Evidence 323-334
HASDAI, D., HOLMES, D. R., TOPOL, E. J., BERGER, P. B., CRIGER, D. A., HOCHMAN, J. S., BATES, E. R., VAHANIAN, A., ARMSTRONG, P. W. and WILCOX, R., 1999. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase; results from GUSTO-III European Heart Journal. VOL 20(NUMBER 2), 128-135 WILCOX, R.G., 1999. Anglo Scandinavian Study of Early Thrombolysis: ASSET. In: Efficacy of Myocardial Infarction Therapy: an evaluation of Clinical Trials Evidence 15-24
ALEXANDER, J. H., HARRINGTON, R. A., TUTTLE, R. H., BERDAN, L. G., LINCOFF, A. M., DECKERS, J. W., SIMOONS, M. L., GUERCI, A., HOCHMAN, J. S. and WILCOX, R. G., 1999. Prior Aspirin Use Predicts Worse Outcomes in Patients With Non-ST-Elevation Acute Coronary Syndromes American Journal of Cardiology. VOL 83(NUMBER 8), 1147-1151 WILCOX, R.G., ANTMAN, E., BRAUNWALD, E., NEUHAUS, K. and SKENE, A.M., 1999. In-Time II: an equivalence trial of single bolus lanoteplase vs. accelerated alteplase in patients with acute myocardial infarction Heart. 81 Suppl.1, 38
OHMAN, E M, ARMSTRONG, P W, WHITE, H D, GRANGER, C B, WILCOX, R G, WEAVER, W D, GIBLER, W B, STEBBINS, A L, CIANCIOLO, C, CALIFF, R M and TOPOL, E J, 1999. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. American Journal of Cardiology. 84(11), 1281-6 STOREY, R.F., OLDROYD, K.G. and WILCOX, R.G., 1999. First clinical study of the novel platelet ADP receptor (P2T-) antagonist AR-C69931MX, assessing safety, tolerability and activity in patients with acute coronary syndromes Circulation (Baltimore). 100, I-710
STOREY, R F, WILCOX, R G and HEPTINSTALL, S, 1998. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation (Baltimore). 98(16), 1616-21
SZABADI, E., BRADSHAW, C. M., BOSTON, P. F. and LANGLEY, R. W., 1998. The Human Pharmacology of Reboxetine Human Psychopharmacology: Clinical and Experimental. VOL 13 SUPP/1, S3-S12 ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1998. Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo British Journal of Clinical Pharmacology. VOL 45(NUMBER 3), 271-276 ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1998. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. Journal of Psychopharmacology. 12(3), 239-45 BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1998. Sensitivity of the fear-inhibited light reflex to diazepam Psychopharmacology. VOL 135(NUMBER 1), 93-98 BITSIOS, P., LANGLEY, R. W., TAVERNOR, S., PYYKKOE, K., SCHEININ, M., SZABADI, E. and BRADSHAW, C. M., 1998. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man British Journal of Clinical Pharmacology. VOL 45(NUMBER 6), 551-558 WOGAR, M. A., VAN DEN BROEK, M. D., BRADSHAW, C. M. and SZABADI, E., 1998. A new performance-curve method for the detection of simulated cognitive impairment British Journal of Clinical Psychology. VOL 37(NUMBER 3), 327-340
BITSIOS, P., SZABADI, E. and BRADSHAW, C. M., 1998. The effects of clonidine on the fear-inhibited light reflex Journal of Psychopharmacology. VOL 12(NUMBER 2), 137-145 HO, M.-Y., AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., BRADSHAW, C. M. and SZABADI, E., 1998. 5-Hydroxytryptamine and impulse control: prospects for a behavioural analysis Journal of Psychopharmacology. VOL 12(NUMBER 1), 68-78 CHIANG, T.-J., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1998. The influence of `switching' on the psychometric function in the free-operant psychophysical procedure Behavioural Processes. VOL 44(ISSUE 2), 197-209 AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1998. Effect of destruction of noradrenergic neurones with DSP4 on performance on a free-operant timing schedule Psychopharmacology. VOL 136(NUMBER 3), 235-242 WILCOX, R.G., 1998. Horizons in Medicine
GIBLER, W. B., WILCOX, R. G., BODE, C., CASTAIGNE, A. D., DELOOZ, H., ELICH, D., FOX, K. A. A., KEREIAKES, D. J., RUPPRECHT, H. and TOPOL, E. J., 1998. Prospective Use of Glycoprotein IIb/IIIa Receptor Blockers in the Emergency Department Setting Annals of Emergency Medicine. VOL 32(NUMBER 6), 712-722 ARYA, D. K., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1997. Comparison of the effects of high ambient temperature and clonidine on autonomic functions in man Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 355(NUMBER 3), 376-383 ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1997. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo British Journal of Clinical Pharmacology. VOL 44(NUMBER 1), 61-68 HO, M.-Y., WOGAR, M. A., BRADSHAW, C. M. and SZABADI, E., 1997. Choice between Delayed Reinforcers: Interaction between Delay and Deprivation Level Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. VOL 50(NUMBER 3), 193-202
AL-RUWAITEA, A. S. A., AL-ZAHRANI, S. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1997. Effect of central 5-hydroxytryptamine depletion on performance in the "time-left" procedure: further evidence for a role of the 5-hydroxytryptaminergic pathways in behavioural "switching" Psychopharmacology. VOL 134(NUMBER 2), 179-186 AL-ZAHRANI, S. S. A., AL-RUWAITEA, A. S. A., HO, M.-Y., BRADSHAW, C. M. and SZABADI, E., 1997. Destruction of central noradrenergic neurones with DSP4 impairs the acquisition of temporal discrimination but does not affect memory for duration in a delayed conditional discrimination task Psychopharmacology. VOL 130(NUMBER 2), 166-173 AL-ZAHRANI, S. S. A., HO, M.-Y., AL-RUWAITEA, A. S. A., BRADSHAW, C. M. and SZABADI, E., 1997. Effect of destruction of the 5-hydroxytryptaminergic pathways on temporal memory: quantitative analysis with a delayed interval bisection task Psychopharmacology. VOL 129(NUMBER 1), 48-55 AL-RUWAITEA,A.S., AL-ZAHRANI,S.S., HO,M., BRADSHAW,C.M. and SZABADI,E., 1997. 5-Hydroxytryptamine and interval timing.. In: BRADSHAW, C.M., ed., Time and behaviour: psychological and neurobehavioural analyses . Elsevier. 517-570
ABDULJAWAD, K A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1997. Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by 'prepulses' in man. Journal of Psychopharmacology. 11(1), 29-34 BRADSHAW, C.M. and SZABADI, E., eds., 1997. Time and behaviour: psychological and neurobehavioural analyses Elsevier.
ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1996. Cumulative and Noncumulative Dose-Response Curves to Noradrenaline on the Dorsal Hand Vein Journal of Pharmacological and Toxicological Methods. VOL 36(NUMBER 2), 77-80 BITSIOS, P, LANGLEY, R W, SZABADI, E and BRADSHAW, C M, 1996. Comparison of the effects of clonidine on tyramine- and methoxamine-evoked mydriasis in man. British Journal of Clinical Pharmacology. 41(4), 269-75 MORTLOCK, S A, LANGLEY, R W, BRADSHAW, C M and SZABADI, E, 1996. Effect of locally applied prazosin on the kinetics of the pupillary light reflex. British Journal of Clinical Pharmacology. 42(2), 236-8 ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1996. The opposite effects of amitriptyline on noradrenaline- and methoxamine-evoked venoconstriction in man Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 354(NUMBER 1), 25-29 ABDELMAWLA, A. H., LANGLEY, R. W., SZAHADI, E. and BRADSHAW, C. M., 1996. Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline Naunyn-Schmiedeberg's Archives of Pharmacology. VOL 353(NUMBER 3), 324-327 AL-ZAHRANI, S S, HO, M Y, VELAZQUEZ MARTINEZ, D N, LOPEZ CABRERA, M, BRADSHAW, C M and SZABADI, E, 1996. Effect of destruction of the 5-hydroxytryptaminergic pathways on behavioural timing and "switching" in a free-operant psychophysical procedure. Psychopharmacology. 127(4), 346-52 AL-ZAHRANI, S S, HO, M Y, MARTINEZ, D N, CABRERA, M L, BRADSHAW, C M and SZABADI, E, 1996. Effect of destruction of the 5-hydroxytryptaminergic pathways on the acquisition of temporal discrimination and memory for duration in a delayed conditional discrimination task. Psychopharmacology. 123(1), 103-10 SZABADI, E. and BRADSHAW, C. M., 1996. Autonomic pharmacology of à~2-adrenoceptors Journal of Psychopharmacology. VOL 10(NUMBER SUP//3), 6-18
HO, M.-Y., AL-ZAHRANI, S. S. A., VELAZQUEZ MARTINEZ, D. N., LOPEZ CABRERA, M., BRADSHAW, C. M. and SZABADI, E., 1996. Effects of desipramine and fluvoxamine on timing behaviour investigated with the fixed-interval peak procedure and the interval bisection task Psychopharmacology. VOL 125(NUMBER 3), 274-284 ABDELMAWLA, A. H., LANGLEY, R. W., SZABADI, E. and BRADSHAW, C. M., 1995. Comparison of the effects of desipramine on noradrenaline-and methoxamine-evoked venoconstriction in man British Journal of Clinical Pharmacology. VOL 40(NUMBER 5), 445
SZABADI,E. and BRADSHAW,C.M., 1995. Affective disorders: Antidepressants. In: KING, D.J, ed., Seminars in Clinical Psychopharmacology 138-192
HO,M.Y., AL-ZAHRANI,S.S., VELAZQUEZMARTINEZ,D.N., LOPEZCABRERA,M., BRADSHAW,C.M. and SZABADI,E., 1995. The role of the ascending 5-hydroxytryptaminergic pathways in timing behaviour: further observations with the interval bisection task Psychopharmacology. 120(2), 213-219 THEOFILOPOULOS, N, MCDADE, G, SZABADI, E and BRADSHAW, C M, 1995. Effects of reboxetine and desipramine on the kinetics of the pupillary light reflex. British Journal of Clinical Pharmacology. 39(3), 251-5 HO,M.Y., VELAZQUEZMARTINEZ,D.N., LOPEZCABRERA,M., AL-ZAHRANI,S.S., BRADSHAW,C.M. and SZABADI,E., 1995. Retarded acquisition of a temporal discrimination following destruction of noradrenergic neurones by systemic treatment with DSP4. Psychopharmacology. 118(3), 332-337 VAN DEN BROEK, M D and BRADSHAW, C M, 1994. Detection of acquired deficits in general intelligence using the National Adult Reading Test and Raven's Standard Progressive Matrices. British Journal of Clinical Psychology. 33 ( Pt 4), 509-15
BRADSHAW, C. M. and SZABADI, E., 1993. Herrnstein's Equation: Data From 110 Rats Psychological Reports. VOL 73(NUMBER 3//PT2), 1355
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1993. Utility of the Wisconsin Card Sorting Test in neuropsychological assessment British Journal of Clinical Psychology. 32(3), 333-343
VANDENBROEK,M.D. and BRADSHAW,C.M., 1993. An investigation of the relationship between perseveration and impulsivenes Personality and Individual Differences. 14(4), 531-534 VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1992. The relationship between Personality and Individual Differences. 13(3), 355-360
WOGAR,M.A., BRADSHAW,C.M. and SZABADI,E., 1992. Choice between delayed reinforcers in an adjusting-delay schedule: the effects of absolute reinforcer size and deprivation level Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 45B(1), 1-13
LEUNG, N K, BRADSHAW, C M and SZABADI, E, 1992. Effect of high ambient temperature on the kinetics of the pupillary light reflex in healthy volunteers. British Journal of Clinical Pharmacology. 33(4), 458-60
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1992. Performance of impulsive and non-impulsive subjects on two temporal differentiation tasks Personality and Individual Differences. 13(2), 169-174 BRADSHAW, C M and SZABADI, E, 1992. Choice between delayed reinforcers in a discrete-trials schedule: the effect of deprivation level. Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 44(1), 1-6
SHAH,K., BRADSHAW,C.M. and SZABADI,E., 1991. Relative and absolute reinforcement frequency as determinants of choice in concurrent variable interval schedules Quarterly Journal of Experimental Psychology. Section B: Comparative and Physiological Psychology. 43B(1), 25-38
SZABADI, E. and BRADSHAW, C.M., eds., 1991. Adrenoceptors: Structure, Mechanisms, Function Birkhauser.
LONGMORE,J., BERRY,J.L., SZABADI,E. and BRADSHAW,C.M., 1990. A comparison of the anticholinergic effects of two formulations of disopyramide in healthy volunteers European Journal of Clinical Pharmacology. 39, 305-309 BAKES,A., BRADSHAW,C.M. and SZABADI,E., 1990. Attenuation of the pupillary light reflex in anxious patients British Journal of Clinical Pharmacology. 30, 377-381
VANDENBROEK,M.D. and BRADSHAW,C.M., 1990. Intellectual decline and the assessment of premorbid intelligence. In: BEECH,J. R. and HARDING L, eds., Assessment of the Elderly NFER-Nelson, London.
THEOFILOPOULOS, N., GRAY, C.M., SZABADI, E. and BRADSHAW, C.M., 1989. Comparison of the effects of fengabine, a novel antidepressant, with those of amitriptyline on psychomotor and autonomic functions in healthy volunteers. Human Psychopharmacology: Clinical and Experimental. 4, 129-134 SHAH,K., BRADSHAW,C.M. and SZABADI,E., 1989. Performance of humans in concurrent variable ratio schedules of monetary reinforcement. Psychological Reports. 65(2), 515-520
BRADSHAW,C.M. and SZABADI,E., 1989. Central neurotransmitter systems and the control of operant behaviour by. In: LIEBMAN, J.M. and COOPER, S.J, eds., The Neuropharmacological Basis of Reward, Clarendon Press.
BANJAR, W M, BRADSHAW, C M and SZABADI, E, 1989. Seasonal variation in responsiveness of human eccrine sweat glands to phenylephrine. British Journal of Clinical Pharmacology. 27(2), 276-8
SZABADI,E. and BRADSHAW,C.M., 1988. Biological markers for anxiety states. In: GRANVILLE-GROSSMAN,K.L. and WING,P., eds., Recent Advances in Clinical Psychiatry 6. Churchill Livingstone. 69-99
THEOFILOPOULOS, N, LONGMORE, J, KERR, F A, SZABADI, E and BRADSHAW, C M, 1988. Consensual pupillary responses to mydriatic and miotic drugs. British Journal of Clinical Pharmacology. 26(6), 697-702 BRADSHAW,C.M. and SZABADI,E., 1988. Quantitative analysis of human operant behavior. In: DAVEY,G. and CULLEN,C., eds., Human Operant Conditioning and Behavior Modification John Wiley & Sons. 225-259
BRADSHAW, C.M., 1988. Biological markers for anxiety states. In: Recent Advances in Clinical Psychiatry 6. 69-99
VAN DEN BROEK, M D, BRADSHAW, C M and SZABADI, E, 1987. Performance of normal adults on the Matching Familiar Figures Test. British Journal of Clinical Psychology. 26 ( Pt 1), 71-2
SZABADI,E. and BRADSHAW,C.M., 1987. Alpha 1 adrenergic receptors in the central nervous system. In: RUFFOLO,R.R., ed., The Alpha 1 Adrenergic Receptors Humana Press. 405-453
VANDENBROEK,M.D., BRADSHAW,C.M. and SZABADI,E., 1987. Behaviour of Personality and Individual Differences. 8(2), 233-239
LONGMORE, J, BANJAR, W, SZABADI, E and BRADSHAW, C M, 1987. Antagonism of phenylephrine-evoked sweating by trazodone and amitriptyline in humans in vivo. British Journal of Clinical Pharmacology. 23(2), 245-6 SZABADI,E. and BRADSHAW,C.M., 1986. Antidepressant drugs and the autonomic nervous system. In: DEAKIN,J.F.W., ed., The Biology of Depression Gaskell. 190-220